We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
DexCom Inc | NASDAQ:DXCM | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.19 | -0.15% | 125.69 | 125.59 | 125.73 | 127.88 | 124.61 | 127.03 | 337,855 | 15:23:25 |
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
000-51222
|
33-0857544
|
(State or other jurisdiction of
incorporation)
|
(Commission File Number)
|
(I.R.S. Employer
Identification Number)
|
|
6340 Sequence Drive, San Diego, CA
|
92121
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
|
(858) 200-0200
|
|
|
(Registrant’s telephone number, including area code)
|
|
|
|
|
|
Amended and Restated 2015 Equity Incentive Plan
|
|
|
(Full Title of the Plans)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Large accelerated Filer
|
|
x
|
|
Accelerated Filer
|
|
☐
|
|
|
|
|
|||
Non-accelerated Filer
|
|
☐
|
|
Smaller reporting company
|
|
☐
|
|
|
|
|
|||
|
|
|
|
Emerging growth company
|
|
☐
|
|
|
|
(2)
|
Represents 2,200,000 additional shares of common reserved for issuance upon the exercise of stock options and the settlement of restricted stock unit awards under the 2015 Plan to be granted by the Registrant. Shares available for issuance under the 2015 Plan were previously registered on a Registration Statement on Form S-8 filed with the Securities and Exchange Commission (the “Commission”) on June 3, 2015 (File No. 333-204699) and on a Registration Statement on Form S-8 filed with the Commission on June 7, 2017 (File No. 333-218562).
|
(3)
|
Estimated pursuant to Rule 457(c) and (h) of the Securities Act, solely for purposes of calculating the registration fee, based on the average of the high and low sales price reported on the Nasdaq Global Select Market on November 6, 2019.
|
|
|
|
|
|
|
|
|
|
Incorporated by Reference
|
|
|
|
|
||
Exhibit
Number
|
|
Exhibit Document
|
|
Form
|
|
File No.
|
|
Date of
First Filing
|
|
Exhibit
Number
|
|
Provided
Herewith
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
X
|
||
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
|
|
X
|
||
|
|
|
|
|
|
|
||||||
23.02
|
|
Consent of Fenwick & West LLP (included in Exhibit 5.01).
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
||||||
24.01
|
|
Power of Attorney (see signature page).
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DEXCOM, INC.
|
||
|
|
|
By:
|
|
/s/ Kevin Sayer
|
|
|
Kevin Sayer
Chairman, President and Chief Executive Officer
|
Signature
|
|
|
Capacity
|
|
Date
|
||
/S/ KEVIN R. SAYER
|
|
Chairman of the Board of Directors, President and Chief Executive Officer (Principal Executive Officer)
|
|
November 13, 2019
|
|||
Kevin R. Sayer
|
|
|
|
||||
|
|
|
|||||
/S/ QUENTIN S. BLACKFORD
|
|
Chief Operating Officer and Chief Financial Officer (Principal Financial and Accounting Officer)
|
|
November 13, 2019
|
|||
Quentin S. Blackford
|
|
|
|
||||
|
|
|
|||||
/S/ MARK FOLETTA
|
|
Lead Independent Director
|
|
November 13, 2019
|
|||
Mark Foletta
|
|
|
|
||||
|
|
|
|||||
/S/ STEVE ALTMAN
|
|
Director
|
|
November 13, 2019
|
|||
Steve Altman
|
|
|
|
||||
|
|
|
|||||
|
|
Director
|
|
|
|||
Nicholas Augustinos
|
|
|
|
||||
|
|
|
|||||
/S/ RICHARD COLLINS
|
|
Director
|
|
November 13, 2019
|
|||
Richard Collins
|
|
|
|
||||
|
|
|
|
|
|||
/S/ BRIDGETTE HELLER
|
|
|
Director
|
|
November 13, 2019
|
||
Bridgette Heller
|
|
|
|
||||
|
|
|
|
|
|||
/S/ BARBARA KAHN
|
|
Director
|
|
November 13, 2019
|
|||
Barbara Kahn
|
|
|
|
||||
|
|
|
|
|
|||
/S/ JAY SKYLER
|
|
Director
|
|
November 13, 2019
|
|||
Jay Skyler, M.D.
|
|
|
|
||||
|
|
|
|
|
|||
/S/ ERIC TOPOL
|
|
Director
|
|
November 13, 2019
|
|||
Eric Topol, M.D.
|
|
|
|
||||
|
|
|
|
|
|
|
|
1 Year DexCom Chart |
1 Month DexCom Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions